Literature DB >> 11733352

STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas.

N Sato1, C Rosty, M Jansen, N Fukushima, T Ueki, C J Yeo, J L Cameron, C A Iacobuzio-Donahue, R H Hruban, M Goggins.   

Abstract

Despite the growing awareness of intraductal papillary-mucinous neoplasms (IPMNs) of the pancreas among clinicians, the molecular features of IPMNs have not been well characterized. Previous reports suggest that inactivation of the STK11/LKB1, a tumor-suppressor gene responsible for Peutz-Jeghers syndrome (PJS), plays a role in the pathogenesis of gastrointestinal hamartomas as well as several cancers, including pancreatic adenocarcinoma. Using polymerase chain reaction amplification of five microsatellite markers from the 19p13.3 region harboring the STK11/LKB1 gene, we analyzed DNA from 22 IPMNs for loss of heterozygosity (LOH). LOH at 19p13.3 was identified in 2 of 2 (100%) IPMNs from patients with PJS and 5 of 20 (25%) from patients lacking features of PJS (7 of 22, 32% overall). Sequencing analysis of the STK11/LKB1 gene in these IPMNs with LOH revealed a germline mutation in one IPMN that arose in a patient with PJS and a somatic mutation in 1 of the 20 sporadic IPMNs. None of the 22 IPMNs showed hypermethylation of the STK11/LKB1 gene. These results suggest that the STK11/LKB1 gene is involved in the pathogenesis of some IPMNs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733352      PMCID: PMC1850608          DOI: 10.1016/S0002-9440(10)63053-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance.

Authors:  H JEGHERS; V A McKUSICK; K H KATZ
Journal:  N Engl J Med       Date:  1949-12-29       Impact factor: 91.245

2.  Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis.

Authors:  H Inoue; T Furukawa; M Sunamura; K Takeda; S Matsuno; A Horii
Journal:  Genes Chromosomes Cancer       Date:  2001-07       Impact factor: 5.006

3.  Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity.

Authors:  T A Sohn; C J Yeo; J L Cameron; C A Iacobuzio-Donahue; R H Hruban; K D Lillemoe
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

4.  Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases.

Authors:  M Tada; M Omata; M Ohto
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

5.  Cancer in Peutz-Jeghers syndrome.

Authors:  K Hizawa; M Iida; T Matsumoto; N Kohrogi; H Kinoshita; T Yao; M Fujishima
Journal:  Cancer       Date:  1993-11-01       Impact factor: 6.860

6.  Allelotype of pancreatic adenocarcinoma.

Authors:  A B Seymour; R H Hruban; M Redston; C Caldas; S M Powell; K W Kinzler; C J Yeo; S E Kern
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

7.  An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas.

Authors:  K Satoh; H Sasano; T Shimosegawa; M Koizumi; T Yamazaki; F Mochizuki; N Kobayashi; T Okano; T Toyota; T Sawai
Journal:  Cancer       Date:  1993-07-01       Impact factor: 6.860

8.  Increased risk of cancer in the Peutz-Jeghers syndrome.

Authors:  F M Giardiello; S B Welsh; S R Hamilton; G J Offerhaus; A M Gittelsohn; S V Booker; A J Krush; J H Yardley; G D Luk
Journal:  N Engl J Med       Date:  1987-06-11       Impact factor: 91.245

9.  Intraductal papillary mucinous neoplasms of the pancreas associated with so-called "mucinous ductal ectasia". Histochemical and immunohistochemical analysis of 29 cases.

Authors:  E Nagai; T Ueki; K Chijiiwa; M Tanaka; M Tsuneyoshi
Journal:  Am J Surg Pathol       Date:  1995-05       Impact factor: 6.394

10.  Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.

Authors:  F Sessa; E Solcia; C Capella; M Bonato; A Scarpa; G Zamboni; N S Pellegata; G N Ranzani; F Rickaert; G Klöppel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more
  90 in total

1.  Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Hanno Matthaei; Alexis L Norris; Athanasios C Tsiatis; Kelly Olino; Seung-Mo Hong; Marco dal Molin; Michael G Goggins; Marcia Canto; Karen M Horton; Keith D Jackson; Paola Capelli; Giuseppe Zamboni; Laura Bortesi; Toru Furukawa; Shinichi Egawa; Masaharu Ishida; Shigeru Ottomo; Michiaki Unno; Fuyuhiko Motoi; Christopher L Wolfgang; Barish H Edil; John L Cameron; James R Eshleman; Richard D Schulick; Anirban Maitra; Ralph H Hruban
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

Review 2.  Molecular signatures of pancreatic cancer.

Authors:  Seung-Mo Hong; Jason Y Park; Ralph H Hruban; Michael Goggins
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

Review 3.  LKB1 signaling in advancing cell differentiation.

Authors:  Lina Udd; Tomi P Mäkelä
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

4.  Intraductal papillary mucinous neoplasms of the pancreas: pathology and molecular genetics.

Authors:  N Volkan Adsay
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452

5.  The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma.

Authors:  Kai Liu; Yue Luo; Hui Tian; Kai-Zhong Yu; Jin-Xian He; Wei-Yu Shen
Journal:  Tumour Biol       Date:  2014-02

Review 6.  From tissue turnover to the cell of origin for pancreatic cancer.

Authors:  Bo Kong; Christoph W Michalski; Mert Erkan; Helmut Friess; Jörg Kleeff
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-12       Impact factor: 46.802

7.  Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.

Authors:  Ji Kon Ryu; Hanno Matthaei; Marco Dal Molin; Seung-Mo Hong; Marcia I Canto; Richard D Schulick; Christopher Wolfgang; Michael G Goggins; Ralph H Hruban; Leslie Cope; Anirban Maitra
Journal:  Pancreatology       Date:  2011-07-12       Impact factor: 3.996

8.  A new approach to managing intraductal papillary mucinous pancreatic neoplasms.

Authors:  Paula Ghaneh; John Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

9.  Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Daniel J Lindner; Robert R Lorenz; Eric Lamarre; Xiao Weihua; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

10.  Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome.

Authors:  Jennifer A Sparr; Prathap Bandipalliam; Mark S Redston; Sapna Syngal
Journal:  Am J Surg Pathol       Date:  2009-02       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.